 Marc Ferrante © ECCO
|
Following the success of the previous workshops, the Clinical Research Committee (ClinCom) of ECCO will run a sixth workshop in 2018.
During past years, endpoints in clinical trials for patients with Inflammatory Bowel Disease (IBD) have evolved substantially. Initially we mainly aimed for clinical remission, but it has become obvious that this is certainly insufficient to alter the natural history of the disease.
